Kiniksa Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Conference
August 04 2020 - 8:00AM
Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that
it will present at the 2020 Wedbush PacGrow Healthcare Conference
on Tuesday, August 11th, 2020 at 1:10 p.m. Eastern Time.
A live webcast of Kiniksa’s presentation will be accessible
through the Investors & Media section of the company’s website
at www.kiniksa.com. A replay of the webcast will be available on
Kiniksa’s website for 14 days following the conference.
About KiniksaKiniksa is a biopharmaceutical
company focused on discovering, acquiring, developing and
commercializing therapeutic medicines for patients suffering from
debilitating diseases with significant unmet medical need.
Kiniksa’s clinical-stage product candidates, rilonacept,
mavrilimumab, vixarelimab and KPL-404, are based on strong biologic
rationale or validated mechanisms, target underserved conditions
and offer the potential for differentiation. These pipeline assets
are designed to modulate immunological pathways that are implicated
across a spectrum of diseases. For more information, please
visit www.kiniksa.com.
Every Second
Counts!™ Kiniksa Investor and Media
ContactMark Ragosa(781) 430-8289mragosa@kiniksa.com |
|
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Apr 2023 to Apr 2024